June 27th, 2024

Effects of psychedelics on neurogenesis and brain plasticity A systematic review

A systematic review examines psychedelics' impact on neurogenesis and brain plasticity, suggesting their potential in treating mood disorders. The study analyzed 205 articles, categorizing findings on various compounds' effects. It includes both experimental and human studies, aiming to inform new therapeutic approaches for neuropsychiatric conditions.

Read original articleLink Icon
Effects of psychedelics on neurogenesis and brain plasticity A systematic review

The systematic review explores the effects of psychedelics on neurogenesis and brain plasticity. It highlights the continuous generation of new neurons in the mammalian brain, known as adult neurogenesis, and its potential link to mood disorders. Psychedelic compounds have shown promise as therapeutic options for neuropsychiatric disorders, with reports suggesting they can increase adult neurogenesis. The review analyzed 205 articles, with 68 meeting the criteria for further review. The findings were categorized into CB1 agonists, NMDA antagonists, harmala alkaloids, tryptamines, and entactogens, detailing their impact on neurogenesis and brain plasticity. The study encompassed both experimental models and human studies, aiming to provide insights into how psychedelics influence the birth of new neurons and other brain processes. The research may contribute to the development of novel therapeutic strategies for neuropsychiatric disorders. The authors disclosed no competing interests, and the preprint is available under a CC-BY-ND 4.0 International license.

Related

Wine Consumption, Diet and Microbiome Modulation in Alzheimer's Disease (2020)

Wine Consumption, Diet and Microbiome Modulation in Alzheimer's Disease (2020)

The article explores the connection between wine polyphenols, microbiome, and Alzheimer's Disease. It emphasizes the role of dietary factors in modulating microbiota to potentially influence AD progression and neurodegenerative mechanisms.

Next-generation psychedelics: should new agents skip the trip?

Next-generation psychedelics: should new agents skip the trip?

Companies are investing in next-generation psychedelics to enhance mental health treatment, focusing on reducing psychoactive effects while maintaining therapeutic benefits. Despite expanding interest and investments, questions persist about efficacy and cost-effectiveness.

Human neuroscience mustn't forget its human dimension

Human neuroscience mustn't forget its human dimension

Human neuroscience advances with AI, focusing on awake brain surgery studies. Emphasis on ethics, consent, and data privacy. Aim for personalized treatments while upholding ethical standards and participant well-being in research.

The brain makes a lot of waste. Now scientists think they know where it goes

The brain makes a lot of waste. Now scientists think they know where it goes

Scientists reveal synchronized brain waves during sleep aid in waste removal, potentially benefiting Alzheimer's and other brain disorders. Research in Nature suggests insights for human brain health and treatment development.

The ketogenic diet improves healthspan and memory in aging mice

The ketogenic diet improves healthspan and memory in aging mice

A study by the Buck Institute and University of Chile found the ketogenic diet boosts memory in aging mice by enhancing synapse function through a new molecular pathway involving β-hydroxybutyrate. Future research will explore interventions for brain health.

Link Icon 1 comments